Hyperfine Q4 EPS $(0.06) Beats $(0.08) Estimate, Sales $5.293M Beat $5.155M Estimate

3/18/2026
Impact: 75
Healthcare

Hyperfine (NASDAQ: HYPR) reported Q4 earnings with a loss of $(0.06) per share, surpassing the analyst estimate of $(0.08) by 25%. This represents a 57.14% improvement from a loss of $(0.14) per share in the same quarter last year. The company achieved quarterly sales of $5.293 million, exceeding the $5.155 million estimate by 2.68%, and marking a 128.05% increase from $2.321 million in the prior year.

AI summary, not financial advice

Share: